Back to feed
ROIVRoivant Sciences Ltd.
CIK 0001635088 · last filing 2d ago · 4 insider transactions
Buy volume
$770.0K
2 buy transactions
Sell volume
$6.63M
2 sell transactions
Net flow
-$5.86M
Net selling
Total flow
$7.40M
4 priced transactions
Disclosure radarcross-source convergence
Divergent3/5 sources
16/100
Recent disclosures · timeline
- Form 42d ago
President & Immunovant CEO · sold $5.86M
- Form 1442d ago
Proposed sale of 500,000 sh ($17.04M) · discretionary
- Form 1443d ago
Proposed sale of 500,000 sh ($17.07M) · discretionary
- Form 1444d ago
Price · ROIV
Live chart by TradingViewLive chart via TradingView. Insider trade price and date are from the underlying SEC filing. Not financial advice.
ROIV insider flow· last 30 days
Buys Sellsnet -$5.86M
Institutional holders · 13F
Q1 2026 vs Q4 2025 · live SEC data9 funds hold$5.11B reported valueNet accumulating(7 adding · 3 reducing)
| Fund | Shares | Value | % of portfolio | QoQ |
|---|---|---|---|---|
| FMR LLC (Fidelity) | 77,981,253 | $2.16B | 0.4% | Add+19% |
| BlackRock Inc | 44,254,260 | $1.23B | 0.1% | Add+7% |
| Vanguard Group Inc | 42,059,041 | $912.68M | 0.1% | Add |
Proposed sales · Form 144
selling intent · live SEC data3 notices$40.74M proposed to sell0/3 under a 10b5-1 plan
| Filed | Filer | Shares | Est. value | Approx. sale | Source of shares | Plan |
|---|---|---|---|---|---|---|
| 2d ago | MAYUKH SUKHATME Officer, Director | 500,000 | $17.04M | Jun 26, 2026 | Exercise of Options Under a Registered Plan | Discretionary |
| 3d ago | MAYUKH SUKHATME Officer, Director | 500,000 | $17.07M | Jun 25, 2026 | Exercise of Options Under a Registered Plan | Discretionary |
Recent insider transactions
| Filed | Insider | Transaction | Shares | Price | Value | Signal | Flags | |
|---|---|---|---|---|---|---|---|---|
2d ago Jun 24, 2026 | Venker Eric President & Immunovant CEO | Buy · M | 200,000 | $3.85 | $770.0K | Mild sell-20 | ||
2d ago Jun 24, 2026 | Venker Eric President & Immunovant CEO | Sell · S | 153,766 | $33.05 | $5.08M | Mild sell-20 | ||
2d ago Jun 24, 2026 | Venker Eric President & Immunovant CEO | Sell · S | 46,234 | $33.51 | $1.55M | Mild sell-20 | ||
2d ago Jun 24, 2026 | Venker Eric President & Immunovant CEO | Buy · M | 200,000 | $0.00 | $0 | Mild sell-20 | Deriv |